Take osteoporosis for a good example; we all know that alcohol and smoking increases the risk of brittle bones later on and women are developing this condition in their forties now which is frightening. Increasingly we are seeing more supplements for joint pain remedies appearing alongside beauty cosmetics on the shelves now which tells you how much of a problem this is becoming.

You can look after your joints by taking omega 3’s and staying active – and don’t forget the calcium girls.

Naturally, there isn’t one. It’s not that there aren’t pills and potions that will help you lose weight, it’s that there are lots of different ones around each of them working on different principles. For example, you can get pills which absorb fat which work wonderfully if you eat a diet with lots of fat or there are those that aim to speed up your metabolism which helps if you are like many people and spend a lot of the day relatively inactive behind a desk and then there’s the likes of websites like www.loseweightfast.net which try to be all things to everyone in the way of advice.

So, yes, the diet pills do work but so does the simple act of cutting down and exercising more – as far as pills go though you need to find the one that targets the reason behind your weight. Bear in mind too that for many of them the effect wears off after a while.

For example if you are wanting to build muscle and burn off fat then you might look at a formulation like nuphedragen. In principle, it sounds like a good idea but you can’t take something like that without first looking at your diet as many of these sort of pills will require you to eat more than normal before they’ll work for you.

To get rid of all that excess fat in your body fat burners are the way to go though here you should be looking towards increasing the amount of exercise that you do as that’ll help the fat reduction.

You see all the experts doing a diet pill comparison and Weight Watchers have adverts on every second page in all the magazines that women buy and read. Slimming pills, slimming shakes, even Tesco now has it’s own diet and now Jenny Craig is set to open over here in the UK having made a fortune in Australia with her revolting microwave diet meals known as ‘universal brown stuff’.

They all make a quick buck out of people who lose a little weight only to put it all back on while on holiday…but they get to keep your money and you keep the weight. Not fair is it?

He has a form of Mesothelioma Cancer which is a direct side effect from his having been a worker in a brick-making factory for so many years. The dust got down his throat and into his lungs…his wife died from a respiratory disease ten years ago and we reckon it was from handling and washing his work clothes for so long. She must have breathed in the asbestos dust all the while…

Anyway, he is tootling along and for most of the time is in some sort of a sitting-up coma condition…but he seems to ‘wake up’ when you bring out the camera. He always had a thing about cameras and photography and even now the sight of a camera does something to him. Strange eh…?

There are many different stretch marks creams on the shelves these days but I always think that it depends on your skin type whether you will get ‘road maps’ or not. Some are worse than others of course but I reckon those ’skinny minnies’ who never seem to ‘bulge’ during pregnancy get them worse, after all, us bigger women have more ’slack’ for ‘give’ don’t we…?

Well, he got acne at 14 and until a year ago tried everything – all the acne treatments you could name and even an antibiotic/steroid once that gave him thrush and a peeling scalp. Very bad that was. But in the past year his skin all of a sudden cleared up and now he has the complexion of a peach. I was so worried about him but now when I get a photo of him I can look at it and enjoy the way he seems so much more confident in himself. Yes, he’s 22 but you always worry about them no matter what their age

But the BBC Watchdog programme found Boots sold the drug to an underage schoolgirl online while both Boots and Lloyds Pharmacy sold Alli to a recovering anorexic over the internet. When the drug was sold in branches of the chemists, patients’ height, weight and BMI were checked – and if under weight they were refused the tablets. But online the vetting procedures were much more slack.
The Alli pills should only be available over the counter without a prescription to over-18s with a high BMI.

Applicants were able to lie about their BMI and their purchase was then approved. Alli prevents the body from absorbing fat in food and in trials helped slimmers lose anything from 10lb to five stone over six months. When confronted with the investigation’s results, Lloyds Pharmacy said it would tighten regulations. I would suggest though to those considering buying Alli over the internet to look elsewhere – because they do not work.

‘Ted, I’d love to see you,’ she said. ‘Why haven’t you come to see me, my darling?’

The letter touched nursing staff so much they devised a plan to bring 90-year-old Mr Williams from the Frenchay Hospital in Bristol, where he was being treated for a heart condition, to Southmead Hospital in the city where his wife was being cared for. And they were just in time. Mr Williams was put in the next bed to his wife, who was also suffering from pneumonia, and they held hands as she passed away just three hours later.

Three days afterwards, Mr Williams, a former engineer, died of heart failure. Yesterday their son Tony, 67, thanked the hospitals involved and paid tribute to his parents, whose joint funeral will be held today.

I always feel sorry for today’s modern men and women who proudly announce how they never intend to marry – how lonely they will one day end up…your friends will not last forever and who will spend the night with you when your youth is over and done with…?

‘Companionship’…that’s what life is all about – and what a shame that love stories like these have to come to an end.

(BEVERLY, MA – EDITOR NEWSWIRE) – INVO Bioscience, Inc. (OTCBB: IVOB), a medical device company focused on treatment options for patients diagnosed with infertility, announced today the signing of an agreement with a South African distribution company Delfran Pharmaceuticals (http://www.delfran.co.za/). Delfran is a drug and medical device distribution company that is looking to bring the low cost INVO procedure into African nations, making infertility treatment affordable to the general public. CEO Katie Karloff stated, “The shortage of a cost effective treatment has left assistance for many couples simply out of reach. We believe that INVO Bioscience partnered with Delfran can bring an affordable infertility procedure to couples in many areas of Africa.”

Dr. Claude Ranoux, President and Chief Scientific Officer, traveled to Cape Town and Johannesburg, South Africa from February 7^th-17^th to perform distributor training.

Delfran Pharmaceuticals will have rights to distribute the INVOcell in the countries of South Africa, Madagascar, Seychelles, Mauritius, Namibia, Botswana, Mozambique, Kenya and Angola. The INVOcell product does not need registration in the African nations outlined in the agreement. The governments offer very little financial support for IVF and the vast majority of cases done are paid for privately. Delfran will look to introduce the INVO procedure first into South Africa and then plans to expand INVO into the other territories of Sub-Saharan Africa.

INVO is also happy to announce the birth of the first INVO babies in Colombia. The babies were born on February 15, 2010 to a couple who had been treated at the CECOLFES Center for Fertility in Colombia.

The mother had developed three Grade 1 embryos in her previous IVF attempt without achieving pregnancy. Due to her previous infertility history, after undergoing INVO she was transferred 3 embryos and this resulted in the birth of triplets. These triplets are a multiple pregnancy that occurred during the 50 patient study performed by CECOLFES. The two baby boys, baby girl and mother are doing well and were home from the Pereira Colombia hospital within a few days. Dr. Elkin Lucena, Laboratory Director of CECOLFES, said, “This is the beginning of a new era in ART and the beginning of more births that we’re expecting from INVO in the following weeks.”

About INVO Bioscience

INVO Bioscience (IVOB) is a medical device company, headquartered in Beverly, Massachusetts, focused on creating simplified, lower cost treatment options for patients diagnosed with infertility. The company’s lead product, the INVOcell, is a novel medical device used in infertility treatment that enables egg fertilization and early embryo development in the woman’s vaginal cavity. The company was founded by Claude Ranoux, MD, a noted expert in the field of reproductive health, infertility and embryology. For more information, please visit www.invobioscience.com.

This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategies, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, as well as statements that include words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions are forward-looking statements. All forward-looking statements involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. Factors that may cause actual results to differ materially from those in the forward-looking statements include those set forth in our filings at www.sec.gov. We are under no obligation to (and expressly disclaim any such obligation to) update or alter our forward-looking statements, whether as a result of new information, future events or otherwise.